Simple Summary Despite the continuous development of treatment technology,
glioblastoma remains a challenge for modern medicine. The standard of care remains a …

Non-small cell lung cancer (NSCLC) is a prominent subtype of lung carcinoma that accounts
for the majority of cancer-related deaths globally, and it is responsible for about 80% to 85 …

Drug combination therapies are superior to monotherapy for cancer treatment in many ways.
Identifying novel drug combinations by screening is challenging for the wet-lab experiments …

The tumor microenvironment (TME) significantly influences cancer evolution and therapeutic
efficacy. Targeting biofunctional molecules to the TME has long been appreciated as a …

Simple Summary The aim of this study was to present and analyze the up-to-date literature
describing the epidemiology, genetics, and histopathology of bladder cancer, as well as the …

Uveal melanoma is a rare cancer in adults, but its treatment is one of the clinical unmet
needs in the melanoma field. Metastatic disease develops in approximately 50% of patients …

Photoimmunotherapy is an emerging treatment modality that uses photothermal,
photodynamic and photochemical processes to fight against cancer by eliciting a robust host …

The use of cetuximab anti-epidermal growth factor receptor (anti-EGFR) antibodies has
opened the era of targeted and personalized therapy in colorectal cancer (CRC). Poor …

Proteases have a fundamental role in maintaining physiological homeostasis, but their
dysregulation results in severe activity imbalance and pathological conditions, including …

BRAF inhibitors (BRAFi) have been approved for the clinical treatment of BRAF-mutant
metastatic melanoma. Although initial responses to BRAFi are generally favorable, acquired …